Patent · US Active

Treatment of cardio-renal disease using PCSK6

US10314894B2 · kind B2 · utility

0Cited by

1References

14Claims

0Family size

Assignee

The Cleveland Clinic Foundation · US

Inventors

Qingyu Wu · Beijing, CN
Shenghan Chen · Beachwood, US

Key dates

Filing date	Feb 12, 2015
Grant date	Jun 11, 2019
Priority date	—
Expiry date	Feb 12, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/21
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating a cardio-renal disease is described that includes administering to a subject in need thereof a therapeutically effective amount of proprotein convertase subtilisin/kexin-6 (PCSK6), or an effective fragment thereof, which functions as a corin activator.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.